Abstract
ObjectiveThe ASTRUM-007 study confirmed the significant efficacy and safety of serplulimab plus chemotherapy for patients with locally advanced/metastatic, programmed cell death-ligand 1 positive oesophageal squamous cell carcinoma (OSCC). The economics...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have